You are on page 1of 17

2.

9
420
7 1

11.6%
9500 1.5

5000

80%
70 55%
2020 4

1 / 17

7 1
5.9% 420 2.9
2020 4
61% 2

200
3%
5% 10%

2010 9500 1.5


5000 180

11.6% 20%
20% 4%
96%
30%50%20%

90%
30%

2 / 17

DM, Diabetes Mellitus

90%
2
1

3 / 17

(IGT) (IFG)

>>

4 / 17

* 50%

*
15 2%10%

* 1020%

*
50%

5 / 17

hypoglycemiaketoacidosis, DKA
nonketotic hyperosmolar coma

microvascular

gangrene(

6 / 17

400

752 10
10111013 200 1674
Thomas Willis

1889
1921
F.G. BantingC.H. Best

2 7mmoL/L

7 / 17

8 / 17

1
2
3
4
5

2%
98%


9 / 17

1.
C-

2.

3.

4.

5.

10 / 17

6.

7.

8.

11 / 17

30

120

12 / 17

GMP
GMP

36

2%
98%

2006 FDA

13 / 17

21

6-12

http://www.zhangzequan.com/img_html/35.htm
http://www.zhangzequan.com/img_html/48.htm

14 / 17

15 / 17

3 3 3

16 / 17

http://www.51cc.com/
http://www.zhangzequan.com/
http://www.tnb61.com/
http://www.diabeteszequan.com/
http://www.zzqdm.com/

24
03517561371 03517561722

7090171@gmail.com
QQ800195138133800


2010

17 / 17

You might also like